#62025TJ0307EU General Court Upholds Acta Endocrinologica Trade Mark Registration
AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.
The ruling allows the figurative EU trade mark “Acta Endocrinologica (Buc)” to move forward despite opposition from the Romanian Society of Endocrinology, which relied on an earlier EU word mark with a similar name. The General Court found no likelihood that consumers would confuse the marks because the relevant goods and services were not similar. The practical effect is narrow: medical publishers, professional societies, and organisations using journal or medical-reporting brands should treat similarity of names as only one part of a trade mark dispute. The overlap in the actual goods and services still matters.
AI-generated summary. May contain errors. Refer to official sources for legal decisions.
Key Changes
- Confirms that the applied-for EU figurative mark can proceed despite opposition based on an earlier similar word mark
- Reinforces that trade mark confusion requires similarity between the relevant goods or services, not just similar wording
- Leaves EUIPO’s decision in place, finding no likelihood of confusion under Article 8(1)(b) of the EU Trade Mark Regulation
Obligations
What this law requires
For an opposition under Article 8(1)(b) of Regulation (EU) 2017/1001, likelihood of confusion requires assessment of whether the goods or services covered by the marks are similar; similarity of the signs alone is not sufficient where the goods and services are not similar.
The General Court concluded that the figurative EU trade mark application for “Acta Endocrinologica (Buc)” could proceed because the relevant goods and services were not similar to those covered by the earlier EU word mark, so there was no likelihood of confusion.